20 LATEST RESOURCES (63 INDEXED)
Relation of Vitamin D Levels with Positive and Negative Symptoms of Schizophrenia – A Hospital Based Cross-Sectional Comparative Study · September 2023
Articles
Industrial Psychiatry Journal
Disability and Quality of Life in Patients with Treatment-Resistant Schizophrenia on Long- Term Clozapine Therapy · June 2023
Articles
Indian Journal of Psychiatry
Dropout Rates and Reasons for Dropout among Patients Receiving Clozapine · June 2023
Articles
Indian Journal of Psychiatry
Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia · May 2023
Abstracts
Journal of Clinical Psychopharmacology
Oral versus Long-Acting Injectable Antipsychotic in First Episode Schizophrenia: A 12 Weeks Interventional Study · April 2023
Articles
Indian Journal of Psychiatry
Family Intervention for Expressed Emotion in Schizophrenia: Indian Context · April 2023
Articles
Indian Journal of Psychiatry
Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients with Treatment-Resistant Schizophrenia · March 2023
Abstracts
Journal of Clinical Psychopharmacology
Impact of a Caffeine Restriction Policy on Inpatients with Schizophrenia: A Pre-Post Comparison Using Electronic Health Records · March 2023
Abstracts
Journal of Clinical Psychopharmacology
Lurasidone Augmentation of Clozapine in Refractory Schizophrenia: A Case Series · March 2023
Abstracts
Journal of Clinical Psychopharmacology
Early versus Late Administration of Long-Acting Injectable Antipsychotic Agents among Patients with Newly Diagnosed Schizophrenia: An Analysis of a Commercial Claims Database · February 2023
Articles
International Clinical Psychopharmacology
Patterns of Antipsychotic Prescription and Accelerometer-Based Physical Activity Levels in People with Schizophrenia Spectrum Disorders: A Multicenter, Prospective Study · January 2023
Articles
International Clinical Psychopharmacology
a-Lipoic Acid as Adjunctive Treatment for Schizophrenia: A Randomized Double-Blind Study · January 2023
Abstracts
Journal of Clinical Psychopharmacology
Pimavanserin Exposure-Response Analyses in Patients with Schizophrenia: Results from the Phase 2 ADVANCE Study · November 2022
Articles
Journal of Clinical Psychopharmacology
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients with Schizophrenia Based on Therapeutic Drug Monitoring Data · November 2022
Abstracts
Journal of Clinical Psychopharmacology
Clozapine Blood Concentration Predicts Corrected QT-Interval Prolongation in Patients with Psychoses · November 2022
Abstracts
Journal of Clinical Psychopharmacology
The Dilemma of Polypharmacy in Psychosis: Is It Worth Combining Partial and Full Dopamine Modulation? · November 2022
Articles
International Clinical Psychopharmacology
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Family Care Burden and Its Association with Psychological Distress among Caregivers of Chronic Patients with Schizophrenia · September 2022
Articles
Journal of Public Health and Primary Care
Drug-Associated Liver Injury Related to Antipsychotics: Exploratory Analysis of Pharmacovigilance Data · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Comparison of Extrapyramidal Symptoms among Outpatients with Schizophrenia on Long-Acting Injectable Antipsychotics · September 2022
Abstracts
Journal of Clinical Psychopharmacology